A recent report by The Lancet Diabetes & Endocrinology Commission calls for a shift in obesity diagnosis, proposing a more comprehensive and clinically relevant approach.
Ahead of World Pancreatic Cancer Day, Professor Matthias Löhr, a member of the UEG Public Affairs Committee, explains why we must increase pancreatic cancer awareness.
Here, we find out about the role that the National Institute of Environmental Health Sciences, a publicly-funded institute, when it comes to funding obesity research in the U.S. today.
Cardiovascular diseases are on the rise, but so is confusion as to how to prevent them. Shaun Ingram, MD of Cardiac Science takes a look at the data, shares his views and strikes a cautious note of optimism.
Obesity is a growing problem around the world, with many negative consequences for both individuals and societies. Research by Professor Barry M. Popkin and his colleagues at the University of North Carolina (UNC) aims to lead us beyond the current obesity epidemic.
New government investment in health research will help tackle the biggest challenges over the next 5 years, including dementia, obesity and mental health.
Around four million people in the UK carry genetic variants that protect them from obesity, type 2 diabetes and heart disease, suggests new research from the University of Cambridge.
A group of experts from the University of California, Davis and the University of Southern California explain the extent to which environmental chemicals are contributing to the obesity epidemic.
Public Health England have released a report which shows those suffering with severe mental illnesses experience worse physical health compared to the general population.
According to latest research, nearly a third of children today aged two to 15 are classed as overweight or obese and younger generations are experiencing childhood obesity at earlier ages.
The gap in the long process of progressing a novel scientific insight into a new medicine is often called “the valley of death”. Read below to understand how the strategic alliance between University of Oxford and Novo Nordisk is aiming to combat type 2 diabetes by bridging this gap.
